POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	1olx	2-OXOISOVALERATE DEHYDROGENASE BETA SUBUNIT (Homo sapiens)	4 / 6	LEU B 275 LEU B 276 ILE B 291 ARG B 309	None	1.01A	11.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	1tu3	RAB GTPASE BINDING EFFECTOR PROTEIN 1 (Homo sapiens)	4 / 6	LEU F 832 LEU F 828 ILE F 835 ARG F 834	None	0.89A	13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	1xa6	BETA2-CHIMAERIN (Homo sapiens)	4 / 6	LEU A 266 ASP A 265 ILE A 269 ARG A 268	None	0.93A	8.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	2hgs	PROTEIN (GLUTATHIONE SYNTHETASE) (Homo sapiens)	4 / 6	LEU A 426 LEU A 449 ILE A 428 ARG A 125	None None None SO4  A 505 ( 3.0A)	1.07A	8.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	2oq5	TRANSMEMBRANE PROTEASE, SERINE 11E (Homo sapiens)	4 / 6	LEU A  85 LEU A 108 ILE A  88 ARG A  87	None	0.93A	10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	2q9q	DNA REPLICATION COMPLEX GINS PROTEIN PSF1 (Homo sapiens)	4 / 6	LEU C  84 LEU C  80 ILE C  87 ARG C  86	None	0.98A	12.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	2w7a	LINE-1 ORF1P (Homo sapiens)	4 / 6	LEU A 160 LEU A 158 ILE A 247 ARG A 248	None	1.05A	16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	2xac	VASCULAR ENDOTHELIAL GROWTH FACTOR B (Homo sapiens)	4 / 6	LEU A  81 LEU A  90 ILE A  83 ARG A  84	None	1.06A	13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	3iq2	SORTING NEXIN-7 (Homo sapiens)	4 / 6	LEU A 125 LEU A 121 ILE A 128 ARG A 127	None	0.78A	20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	3w4u	HEMOGLOBIN SUBUNIT ZETA (Homo sapiens)	4 / 6	LEU A 109 LEU A 106 ILE A  24 ARG A  31	None	1.05A	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	4bc5	XYLULOSE KINASE (Homo sapiens)	4 / 6	LEU A 121 LEU A  72 ASP A  73 ARG A 120	None	0.93A	6.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	4r0i	SUPPRESSOR OF TUMORIGENICITY 14 PROTEIN (Homo sapiens)	4 / 6	LEU A  85 LEU A 108 ILE A  88 ARG A  87	None	0.83A	9.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	4rz9	PRE-MRNA-SPLICING FACTOR 38A (Homo sapiens)	4 / 6	LEU A 123 ASP A 126 ILE A 130 ARG A 128	None	0.99A	11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	4u9v	N-ALPHA-ACETYLTRANSF ERASE 40 (Homo sapiens)	4 / 6	LEU B 173 LEU B 214 ILE B 156 ARG B 216	ACO  B 301 ( 4.2A) None None None	1.01A	10.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	4wtv	PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-BETA,ENDOLYSIN,PHO SPHATIDYLINOSITOL 4-KINASE TYPE 2-BETA (Escherichia virus T4; Homo sapiens)	4 / 6	LEU A 293 LEU A 296 ASP A 297 TRP A 364	None	1.05A	6.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	4yu9	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE (Homo sapiens)	4 / 6	LEU A  73 LEU A  70 ILE A  91 ARG A  94	None	0.94A	9.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	4zih	APOPTOSIS REGULATOR BAX (Homo sapiens)	4 / 6	LEU A  63 LEU A  59 ILE A  66 ARG A  65	None	0.87A	14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	5gl7	METHIONINE--TRNA LIGASE, CYTOPLASMIC (Homo sapiens)	4 / 6	LEU A 622 LEU A 621 ILE A 701 ARG A 702	None	0.95A	5.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	5nqa	POLYPEPTIDE N-ACETYLGALACTOSAMIN YLTRANSFERASE 4 (Homo sapiens)	4 / 6	LEU A 474 LEU A 458 ILE A 453 ARG A 449	None	1.03A	22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	5u2n	NICOTINAMIDE PHOSPHORIBOSYLTRANSF ERASE (Homo sapiens)	4 / 6	LEU A 325 LEU A 328 ILE A 378 ARG A 349	None	1.04A	7.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	5xgc	RAP1 GTPASE-GDP DISSOCIATION STIMULATOR 1 (Homo sapiens)	4 / 6	LEU A 424 LEU A 421 ILE A 381 ARG A 378	None	1.03A	6.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	6eti	ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2 (Homo sapiens)	4 / 6	LEU A 228 LEU A 225 ILE A 196 ARG A 193	None	0.83A	20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_A_RIMA199_1 (MATRIX PROTEIN 2)	6f1t	CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,DYNEIN HEAVY CHAIN,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,DYNEIN HEAVY CHAIN,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1 (Homo sapiens)	4 / 6	LEU e 285 LEU e 281 ILE e 288 ARG e 287	None	0.96A	24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	1qqg	INSULIN RECEPTOR SUBSTRATE 1 (Homo sapiens)	4 / 6	LEU A  66 LEU A 113 ILE A  64 ARG A  43	None	1.03A	9.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	2afg	ACIDIC FIBROBLAST GROWTH FACTOR (Homo sapiens)	4 / 6	LEU A  23 LEU A 111 ILE A  25 ARG A  24	None	1.16A	16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	2hgs	PROTEIN (GLUTATHIONE SYNTHETASE) (Homo sapiens)	4 / 6	LEU A 207 LEU A 205 ILE A 242 ARG A 237	None	1.14A	8.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	2no2	HUNTINGTIN-INTERACTI NG PROTEIN 1 (Homo sapiens)	4 / 6	LEU A 517 LEU A 513 ILE A 520 ARG A 519	None	0.93A	15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	2ocf	ESTROGEN RECEPTOR (Homo sapiens)	4 / 6	LEU A 539 LEU A 540 ASP A 351 ILE A 358	None	1.14A	16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	2ocf	ESTROGEN RECEPTOR FIBRONECTIN (Homo sapiens)	4 / 6	LEU A 539 LEU A 540 ASP A 351 ARG D  33	None	1.15A	16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	2v5o	CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR (Homo sapiens)	4 / 6	LEU A2028 LEU A2005 TRP A2015 ILE A2026	None	1.15A	5.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	2xwu	IMPORTIN13 (Homo sapiens)	4 / 6	LEU B 450 LEU B 453 ILE B 495 ARG B 497	None	0.93A	3.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	3g04	THYROTROPIN RECEPTOR (Homo sapiens)	4 / 6	LEU C  64 LEU C  89 ASP C  86 ILE C  44	None	1.16A	10.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	3su8	PLEXIN-B1 (Homo sapiens)	4 / 6	LEU X1958 ASP X1959 ILE X2056 ARG X2057	None	1.17A	6.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	4hne	PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-ALPHA (Homo sapiens)	4 / 6	LEU A 297 LEU A 300 ASP A 301 TRP A 366	LEU  A 297 ( 0.5A) LEU  A 300 ( 0.5A) ASP  A 301 ( 0.6A) TRP  A 366 ( 0.5A)	1.08A	7.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	4or2	SOLUBLE CYTOCHROME B562, METABOTROPIC GLUTAMATE RECEPTOR 1 (Escherichia coli; Homo sapiens)	4 / 6	LEU A1010 LEU A1014 TRP A1007 ILE A1102	None	0.95A	11.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	4wtv	PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-BETA,ENDOLYSIN,PHO SPHATIDYLINOSITOL 4-KINASE TYPE 2-BETA (Escherichia virus T4; Homo sapiens)	4 / 6	LEU A 293 LEU A 296 ASP A 297 TRP A 364	None	0.95A	6.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	5eut	PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-ALPHA,ENDOLYSIN,PH OSPHATIDYLINOSITOL 4-KINASE TYPE 2-ALPHA (Escherichia virus T4; Homo sapiens)	4 / 6	LEU A 297 LEU A 300 ASP A 301 TRP A 366	None	1.01A	13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	5fwm	HEAT SHOCK PROTEIN HSP 90 BETA (Homo sapiens)	4 / 6	LEU A 657 LEU A 654 ILE A 680 ARG A 682	None	0.88A	6.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	5iy9	DNA-DIRECTED RNA POLYMERASE II SUBUNIT RPB1 DNA-DIRECTED RNA POLYMERASE II SUBUNIT RPB6 (Homo sapiens)	4 / 6	LEU F  90 LEU F  91 ASP F  88 ILE A 455	None	1.10A	16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	5nwm	NUCLEAR RECEPTOR COACTIVATOR 1 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (Homo sapiens)	4 / 6	LEU B 805 LEU B 802 ASP B 801 ILE A 273	None	1.06A	19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	5toa	ESTROGEN RECEPTOR BETA (Homo sapiens)	4 / 6	LEU A 491 LEU A 492 ASP A 489 TRP A 335	None	1.16A	14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	6dd3	CYTOSOLIC PURINE 5'-NUCLEOTIDASE (Homo sapiens)	4 / 6	LEU A 392 LEU A 388 ILE A 423 ARG A 422	None	1.10A	17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	1bo9	PROTEIN (ANNEXIN I) (Homo sapiens)	4 / 6	LEU A  52 LEU A  56 ILE A  40 ARG A  37	None	0.97A	26.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	1bp1	BACTERICIDAL/PERMEAB ILITY-INCREASING PROTEIN (Homo sapiens)	4 / 6	LEU A  29 LEU A  25 ILE A  32 ARG A  31	None PC1  A 777 ( 4.1A) None None	0.99A	6.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	1tu3	RAB GTPASE BINDING EFFECTOR PROTEIN 1 (Homo sapiens)	4 / 6	LEU F 832 LEU F 828 ILE F 835 ARG F 834	None	1.01A	13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	2edw	OBSCURIN (Homo sapiens)	4 / 6	LEU A  64 LEU A  55 ILE A  66 ARG A  67	None	0.76A	17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	2hgs	PROTEIN (GLUTATHIONE SYNTHETASE) (Homo sapiens)	4 / 6	LEU A 426 LEU A 449 ILE A 428 ARG A 125	None None None SO4  A 505 ( 3.0A)	0.98A	8.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	2kdd	BOREALIN (Homo sapiens)	4 / 6	LEU A 269 LEU A 265 ILE A 272 ARG A 268	None	0.91A	19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	2xac	VASCULAR ENDOTHELIAL GROWTH FACTOR B (Homo sapiens)	4 / 6	LEU A  81 LEU A  90 ILE A  83 ARG A  84	None	0.99A	13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	3iq2	SORTING NEXIN-7 (Homo sapiens)	4 / 6	LEU A 125 LEU A 121 ILE A 128 ARG A 127	None	0.87A	20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	4bc5	XYLULOSE KINASE (Homo sapiens)	4 / 6	LEU A 121 LEU A  72 ASP A  73 ARG A 120	None	0.95A	6.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	4r0i	SUPPRESSOR OF TUMORIGENICITY 14 PROTEIN (Homo sapiens)	4 / 6	LEU A  85 LEU A 108 ILE A  88 ARG A  87	None	0.97A	9.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	4rz9	PRE-MRNA-SPLICING FACTOR 38A (Homo sapiens)	4 / 6	LEU A 123 ASP A 126 ILE A 130 ARG A 128	None	0.92A	11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	4u9v	N-ALPHA-ACETYLTRANSF ERASE 40 (Homo sapiens)	4 / 6	LEU B 173 LEU B 214 ILE B 156 ARG B 216	ACO  B 301 ( 4.2A) None None None	0.90A	10.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	4yu9	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE (Homo sapiens)	4 / 6	LEU A  73 LEU A  70 ILE A  91 ARG A  94	None	0.98A	9.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	5gl7	METHIONINE--TRNA LIGASE, CYTOPLASMIC (Homo sapiens)	4 / 6	LEU A 622 LEU A 621 ILE A 701 ARG A 702	None	1.01A	5.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	5nqa	POLYPEPTIDE N-ACETYLGALACTOSAMIN YLTRANSFERASE 4 (Homo sapiens)	4 / 6	LEU A 474 LEU A 458 ILE A 453 ARG A 449	None	0.99A	22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	5u2n	NICOTINAMIDE PHOSPHORIBOSYLTRANSF ERASE (Homo sapiens)	4 / 6	LEU A 325 LEU A 328 ILE A 378 ARG A 349	None	0.97A	7.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	5u77	OXYSTEROL-BINDING PROTEIN-RELATED PROTEIN 8 (Homo sapiens)	4 / 6	LEU A 103 LEU A  98 ILE A 105 ARG A  18	None NDB  A 201 (-4.3A) None None	0.94A	16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	6cwx	RIBONUCLEASE P PROTEIN SUBUNIT P25 (Homo sapiens)	4 / 6	LEU B 135 LEU B  97 ILE B 137 ARG B  96	None None None SO4  B 203 (-4.0A)	1.00A	16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	6eti	ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2 (Homo sapiens)	4 / 6	LEU A 228 LEU A 225 ILE A 196 ARG A 193	None	0.77A	20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_C_RIMC399_1 (MATRIX PROTEIN 2)	6f1t	CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,DYNEIN HEAVY CHAIN,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,DYNEIN HEAVY CHAIN,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1,CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1 (Homo sapiens)	4 / 6	LEU e 285 LEU e 281 ILE e 288 ARG e 287	None	0.96A	24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	1ldj	CULLIN HOMOLOG 1 (Homo sapiens)	4 / 6	ILE A  28 ARG A  25 LEU A  24 LEU A  96	None	1.06A	5.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	2lr8	CASP8-ASSOCIATED PROTEIN 2 (Homo sapiens)	4 / 6	ILE A  25 ARG A  56 LEU A  60 LEU A  46	None	0.91A	18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	2nmp	CYSTATHIONINE GAMMA-LYASE (Homo sapiens)	4 / 6	ILE A  41 LEU A  43 LEU A 254 ASP A 251	None	1.02A	8.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	3nwn	KINESIN-LIKE PROTEIN KIF9 (Homo sapiens)	4 / 6	TRP A  53 ILE A  35 LEU A 331 LEU A  37	None	1.05A	11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	4o3m	BLOOM SYNDROME PROTEIN (Homo sapiens)	4 / 6	ILE A 882 ARG A 883 LEU A 908 ASP A 911	None	0.97A	6.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	4or2	SOLUBLE CYTOCHROME B562, METABOTROPIC GLUTAMATE RECEPTOR 1 (Escherichia coli; Homo sapiens)	4 / 6	ILE A1102 ARG A1098 LEU A1068 LEU A1106	None	1.02A	11.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	5exr	DNA POLYMERASE ALPHA CATALYTIC SUBUNIT (Homo sapiens)	4 / 6	ILE C1006 LEU C 858 LEU C 984 ASP C1004	None	1.00A	3.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	5n4w	CULLIN-2 (Homo sapiens)	4 / 6	ILE A 319 LEU A 315 LEU A 372 ASP A 369	None	1.07A	5.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	5n7f	MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAIN-CONTAINING PROTEIN 1,ANNEXIN A2 (Homo sapiens)	4 / 6	ILE A 671 ARG A 674 LEU A 653 ASP A 649	None GOL  A 903 ( 3.8A) None GOL  A 903 (-3.5A)	1.07A	8.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	5ool	39S RIBOSOMAL PROTEIN L37, MITOCHONDRIAL (Homo sapiens)	4 / 6	ILE 5 314 ARG 5 310 LEU 5 355 LEU 5 121	None	1.00A	7.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_D_RIMD499_1 (MATRIX PROTEIN 2)	5veu	CYTOCHROME P450 3A5 (Homo sapiens)	4 / 6	ILE A 276 LEU A 261 LEU A 295 ASP A 292	None	1.06A	9.07